Peptide Library

MK-677 (Ibutamoren)

Ibutamoren

Orally active ghrelin receptor agonist studied for GH/IGF-1 secretion.

Baseline Labs Generally Required
Provider Evaluation Required

Meet with one of our licensed medical providers to determine whether peptide therapy is appropriate for you. If clinically appropriate, we'll create a personalized treatment plan and coordinate your care through appropriate pharmacy channels in accordance with applicable laws and regulations.

  • Licensed medical provider evaluation
  • Individualized treatment plan
  • Ongoing clinical support
Quick Answer

MK-677 (Ibutamoren) is Orally active ghrelin receptor agonist studied for GH/IGF-1 secretion. Whether it is appropriate depends on your medical history, goals, current medications, and testing — evaluated by a licensed VidaVital Medical provider during a live consultation. Educational content only; not medical advice.

Key Takeaways
  • MK-677 (Ibutamoren) is an educational topic currently being studied.
  • Baseline labs are generally required before a provider considers this therapy.
  • Providers may evaluate it in hormone-health, recovery, longevity.
  • A licensed VidaVital provider must complete a live consultation before any treatment is prescribed.

What is it?

Orally active ghrelin receptor agonist studied for GH/IGF-1 secretion. A licensed provider reviews suitability, monitoring, and any needed testing during a live consultation.

What may it support?

  • Recovery research
  • Sleep quality research

Where might it fit?

intermediate pathwayadvanced pathwayhormone healthrecoverylongevity

Bloodwork & monitoring

Baseline status
Baseline Labs Generally Required
Common tests
  • CMP
  • CBC
  • Lipid panel
The provider determines follow-up cadence individually.
The provider determines final requirements.

Potential side effects

  • Injection-site reaction
  • Mild GI discomfort
  • Rare allergic reaction

Who may not be a candidate?

  • • Pregnancy
  • • Active malignancy without oncology clearance

Drug interactions

  • • Providers review all medications during consultation

Regulatory disclosures

This therapy has limited clinical evidence or may be investigational. Availability may be restricted, and inclusion on this website does not mean that VidaVital Medical currently prescribes or dispenses it.

Speak With a Licensed Medical Provider

If you're interested in learning whether MK-677 (Ibutamoren) may be appropriate for your health goals, schedule a consultation with a licensed VidaVital Medical provider. Your provider will review your medical history, discuss available treatment options, and determine whether any therapy is clinically appropriate for your individual needs.

A licensed VidaVital Medical provider must complete a live video consultation before determining whether this treatment is medically appropriate.

Frequently asked questions

Do I need bloodwork first?
Your provider decides during your live consultation.
Will VidaVital prescribe this to me?
Only if a licensed provider determines it is medically appropriate after a full evaluation.

Sources

  • Provider-reviewed clinical summary — reviewed 2026-01-15 by VidaVital Medical

Related therapies

Interested in MK-677 (Ibutamoren)?

Meet with one of our licensed medical providers to determine whether it's appropriate for you.

If clinically appropriate, we'll create a personalized treatment plan and coordinate your care through appropriate pharmacy channels in accordance with applicable laws and regulations.

  • Personalized evaluation
  • Licensed medical provider review
  • Individualized treatment plan
  • Ongoing clinical support
Request Consultation
The information on this website is for educational purposes and does not constitute medical advice, diagnosis, or a prescription. Treatment eligibility, medication selection, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed medical provider after a live consultation and review of the patient's medical history.